Back to search

The University of Edinburgh

International Multicentre Project Auditing COVID-19 in Trauma & Orthopaedics (IMPACT): using routinely collected and audit derived health data to evaluate and predict the effects of Coronavirus Disease 2019 on patients with a hip fracture

Abstract

dc:description.abstract

INTRODUCTION: Patients who suffer a hip fracture are frail, co-morbid, and have a significantly higher mortality risk than age-adjusted uninjured people. A small number of studies have suggested that hip fracture patients affected by COVID-19 have an increased mortality rate compared to unaffected patients, however shortcomings within the available literature include challenges relating to inconsistent diagnostic criteria, reporting standards, short follow-up durations, and the use of unadjusted analyses. AIMS: The aims of this thesis were to assess the following in the context of acute hip fracture: 1)The prevalence of COVID-19. 2)Patterns of disease transmission. 3)The independent effects of COVID-19 on mortality risk. 4)Factors associated with poor outcomes among patients with COVID-19. 5)The non-lethal effects of COVID-19. 6)The effects of the COVID-19 pandemic on clinical services. 7)Strategies to reduce the risk of morbidity and mortality associated with COVID-19. METHODS: The International Multicentre Project Auditing COVID-19 in Trauma & Orthopaedics (IMPACT) is a global research collaboration that was established in April 2020 to coordinate a rapid and practical clinician-led research response to the COVID-19 pandemic. Seven health data-driven IMPACT Hip Fracture Projects were conducted to investigate COVID-19 in the context of hip fracture patients with the support of the Scottish Committee for Orthopaedics & Trauma (SCOT), Scottish Hip Fracture Audit (SHFA), Public Health Scotland (PHS), and the global Fragility Fracture Network (FFN). An initial multicentre cohort study (IMPACT Scot) included 317 hip fracture patients across six hospitals in Scotland and compared the outcomes of those that had COVID-19 with those that did not. This served as a pilot for the delivery of a nationwide multicentre cohort study (IMPACT Scot 2) of all 833 hip fracture patients that were admitted across Scotland between March-April 2020. This study evaluated the patterns of transmission of COVID-19 within the healthcare system and investigated the early mortality risk associated with COVID-19 during the acute hip fracture episode. A third study (IMPACT Revisited) was conducted which collected one-year follow up data for the IMPACT Scot 2 cohort and facilitated an assessment of the community-based prevalence of COVID-19 and the sustained effects of COVID-19 on the longer-term mortality risk. A large international multicentre cohort study (IMPACT Global), involving 7,090 patients across 112 study centres in 12 countries, was undertaken to investigate: the prevalence of preoperative and postoperative COVID-19; the independent effect of COVID-19 on mortality risk, and factors associated with i) COVID-19 acquisition, and ii) better/poorer survival among COVID-positive patients. To evaluate the findings of these studies within the context of widespread health service disruption, a real-time assessment of the effects of the COVID-19 pandemic on orthopaedic trauma services was conducted using a survey-based ecological study involving 185 hospitals in 14 countries (IMPACT Services Survey). To investigate the non-lethal effects of COVID-19 among hip fracture patients that survive COVID-19, a propensity score-matched study (IMPACT Frailty) of 209 subjects was carried out. A group of 74 patients that had COVID-19 during the acute hip fracture episode was compared to 148 COVID-negative patients, and the independent effect of COVID-19 on clinical frailty and post-discharge care needs was evaluated. In response to the rollout of mass vaccination against COVID-19, a nationwide population-level study (IMPACT Protect) interrogated four government-managed healthcare databases and linked the electronic health records of 13,345 people who sustained a hip fracture between March 2020 and December 2021. This study examined the independent effects of vaccination on the risk of contracting COVID-19 and the associated mortality risk. The IMPACT Hip Fracture Projects were appraised to identify lessons that could be applied to further communicable disease outbreaks, and to inform the establishment and delivery of future collaborative clinical audit and health data research projects. RESULTS: The prevalence of COVID-19 at the time of the acute hip fracture episode was approximately 9.3% in the early stages of the pandemic in Scotland (March to August 2020). When considering the overall period investigated by the IMPACT Hip Fracture Projects (March 2020 to December 2021) the prevalence of COVID-19 at the time of the acute hip fracture episode was 4.5%. COVID-positive patients had a significantly higher 30-day mortality rate compared to COVID-negative patients (34.6% vs 9.0%, p<0.001) and COVID-19 was independently associated with a more than three-fold increased 30-day mortality risk. Increasing age (Hazard ratio [HR] 1.03, 95% CI 1.01-1.05, p=0.028), male sex (HR 2.35, 95% CI 1.66-3.34, p<0.001), renal disease (HR 1.53, 95% CI 1.08-2.18, p=0.017), and pulmonary disease (HR 1.45, 95% CI 1.02-2.06, p=0.039) were independently associated with an increased risk of 30-day mortality. COVID-positive patients also had a significantly higher 365-day mortality rate compared to COVID-negative patients (54.7% vs 27.2%, p<0.001) and COVID-19 within the acute hip fracture episode was independently associated with a two-fold increased likelihood of death within a year (HR 2.03, CI 1.40-2.93, p<0.001). Conversely, a COVID-19 diagnosis made after discharge from the acute hospital stay was not associated with a significantly increased risk of death at one year, when controlling for confounding factors (HR 1.16, CI 0.78-1.70, p=0.462). Both COVID-positive and COVID-negative patients demonstrated a median increase in Clinical Frailty Scale (CFS) score of one level, with the median post-discharge CFS being 7.00 (IQR 5.00-7.00) which indicates severe frailty. COVID-19 was independently associated with a slightly greater increase in frailty, but the magnitude of this effect was smaller following the widespread rollout of vaccination against COVID. Fewer patients that had been COVID-positive during the acute episode were discharged to their own home, and COVID-19 was independently associated with a more than four-fold increased risk of previously home-dwelling patients failing to return home following the acute stay (OR 4.52, CI 2.08-10.34, p<0.001). The rate of COVID-19 among unvaccinated patients was higher than among vaccinated patients, and when controlling for confounding factors unvaccinated patients were more than twice as likely to be COVID-positive within 30 days of a hip fracture (Odds ratio [OR] 2.47, CI 2.06-2.95, p<0.001). Unvaccinated COVID-positive patients had an almost three-fold greater 30-day mortality risk than COVID-negative patients (OR 2.77, CI 2.12-3.62, p<0.001), but the mortality risk of vaccinated COVID-positive patients was no higher than that of COVID-negative patients (OR 0.93, CI 0.53-1.60, p=0.783). During the early stages of the pandemic there was widespread disruption to hip fracture clinical services, and this was attributed to staff redistribution, reallocation of inpatient areas, reduced access to surgical facilities, and patients being managed by non-specialised teams. Delays to definitive surgical management were caused by reduced operating department access, reduced theatre efficiency, longer anaesthetic and transfer times, delays for preoperative COVID-19 testing, and delays caused by the need to use enhanced personal protective equipment. CONCLUSIONS: COVID-19 affecting patients during an acute hip fracture episode was independently associated with a more than three-fold increased risk of death within 30 days of fracture, and a two-fold increased risk of death within a year of fracture at the beginning of the pandemic. Increasing age, male sex, renal disease, and pulmonary disease were independently associated with an increased risk of 30-day mortality. COVID-19 was also independently associated with a greater increase in frailty and post-discharge care requirements, including a more than four-fold increased risk of previously independent patients requiring continuing inpatient or residential care. Vaccination against COVID-19 was effective at reducing the likelihood of contracting COVID-19, and effectively negated the increased mortality risk experienced by patients that were COVID-positive. The IMPACT Hip Fracture projects involved approximately 500 collaborators from 190 centres in 19 countries and analysed data relating to more than 20,000 patients over the course of the pandemic. They are unique in the reporting of population-level data-driven investigations into the effects of COVID-19 in the context of hip fracture, whilst also providing information that will guide the design of services and strategies in anticipation of future communicable disease outbreaks.

Degree

thesis:*
Grantor dc:publisher
The University of Edinburgh
Year dc:date.issued
2024

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Hall, Andrew James
Advisors dc:contributor.advisor
  • Duckworth, Andrew
  • Maclullich, Alasdair
  • White, Tim
  • Clement, Nick

Subjects

dc:subject × 21

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
University of Edinburgh
Base URL
era.ed.ac.uk/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Hall, Andrew James. International Multicentre Project Auditing COVID-19 in Trauma & Orthopaedics (IMPACT): using routinely collected and audit derived health data to evaluate and predict the effects of Coronavirus Disease 2019 on patients with a hip fracture. The University of Edinburgh, 2024. https://hdl.handle.net/1842/42884